Nutritional Status and Circulating Levels of Fat-Soluble Vitamins in Cystic Fibrosis Patients: A Cohort Study and Evaluation of the Effect of CFTR Modulators.
CFTR modulators
cystic fibrosis
malnutrition
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
30 Jan 2023
30 Jan 2023
Historique:
received:
28
09
2022
revised:
15
01
2023
accepted:
27
01
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Improved therapy in CF has led to an overall improvement in nutritional status. The objectives of our study are: to cross-sectionally assess nutritional status and serum levels of fat-soluble vitamins; to retrospectively evaluate the efficacy of modulators on nutritional status and fat-soluble vitamin levels. In patients younger than 2 years of age, we evaluated growth, in patients aged 2-18 years, we assessed BMI z-scores, and in adults, we assessed absolute BMI values. Levels of 25(OH)D, vitamins A, and E were measured. A cross-sectional analysis was conducted on 318 patients, 109 (34.3%) with pancreatic sufficiency. Only three patients were under 2 years old. In 135 patients aged 2-18 years, the median BMI z-score was 0.11, and 5 (3.7%) patients had malnutrition (z-score ≤ 2SD). In 180 adults, the median BMI was 21.8 kg/m Malnutrition is present in a limited number of subjects. The prevalence of subjects with suboptimal 25(OH)D levels is high. ETI showed a beneficial effect on nutritional status and circulating levels of fat-soluble vitamins.
Sections du résumé
BACKGROUND
BACKGROUND
Improved therapy in CF has led to an overall improvement in nutritional status. The objectives of our study are: to cross-sectionally assess nutritional status and serum levels of fat-soluble vitamins; to retrospectively evaluate the efficacy of modulators on nutritional status and fat-soluble vitamin levels.
METHODS
METHODS
In patients younger than 2 years of age, we evaluated growth, in patients aged 2-18 years, we assessed BMI z-scores, and in adults, we assessed absolute BMI values. Levels of 25(OH)D, vitamins A, and E were measured.
RESULTS
RESULTS
A cross-sectional analysis was conducted on 318 patients, 109 (34.3%) with pancreatic sufficiency. Only three patients were under 2 years old. In 135 patients aged 2-18 years, the median BMI z-score was 0.11, and 5 (3.7%) patients had malnutrition (z-score ≤ 2SD). In 180 adults, the median BMI was 21.8 kg/m
CONCLUSIONS
CONCLUSIONS
Malnutrition is present in a limited number of subjects. The prevalence of subjects with suboptimal 25(OH)D levels is high. ETI showed a beneficial effect on nutritional status and circulating levels of fat-soluble vitamins.
Identifiants
pubmed: 36832382
pii: children10020252
doi: 10.3390/children10020252
pmc: PMC9955178
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2015 Jul 16;373(3):220-31
pubmed: 25981758
Pediatr Pulmonol. 2002 Aug;34(2):91-100
pubmed: 12112774
Lancet Respir Med. 2014 Nov;2(11):902-910
pubmed: 25311995
Nutrients. 2021 Aug 24;13(9):
pubmed: 34578785
Pediatrics. 2001 Jan;107(1):1-13
pubmed: 11134427
J Cyst Fibros. 2019 Jan;18(1):94-101
pubmed: 30146268
Front Pharmacol. 2020 Feb 21;10:1662
pubmed: 32153386
J Cyst Fibros. 2022 Sep;21(5):777-783
pubmed: 35396178
N Engl J Med. 2018 Oct 25;379(17):1671-1672
pubmed: 30334694
J Pediatr Pharmacol Ther. 2020;25(3):192-197
pubmed: 32265602
Lung. 2019 Jun;197(3):371-376
pubmed: 30887107
Am J Respir Crit Care Med. 2013 Jun 1;187(11):1219-25
pubmed: 23590265
Chest. 2018 Aug;154(2):383-393
pubmed: 29750923
Thorax. 2002 Jul;57(7):596-601
pubmed: 12096202
J Cyst Fibros. 2018 Jan;17(1):89-95
pubmed: 28711222
J Cyst Fibros. 2021 May;20(3):381-387
pubmed: 33531206
Cells. 2022 May 28;11(11):
pubmed: 35681464
Clin Chem. 2004 Aug;50(8):1415-7
pubmed: 15277348
Lancet Respir Med. 2017 Jul;5(7):557-567
pubmed: 28606620
Semin Respir Crit Care Med. 2019 Dec;40(6):775-791
pubmed: 31659726
J Pharm Biomed Anal. 2006 Sep 18;42(2):232-6
pubmed: 16765550
Lancet Respir Med. 2017 Feb;5(2):107-118
pubmed: 28011037
J Cyst Fibros. 2022 Mar;21(2):265-271
pubmed: 34862121
Nutrition. 2021 May;85:111124
pubmed: 33571868
N Engl J Med. 2017 Nov 23;377(21):2013-2023
pubmed: 29099344
Ital J Pediatr. 2021 Jan 6;47(1):2
pubmed: 33407736
Lancet. 2019 Nov 23;394(10212):1940-1948
pubmed: 31679946
Lancet Respir Med. 2020 Jan;8(1):65-124
pubmed: 31570318
World Rev Nutr Diet. 2022;124:374-381
pubmed: 35240644
J Cyst Fibros. 2017 Nov;16 Suppl 2:S70-S78
pubmed: 28986019
J Acad Nutr Diet. 2021 Jul;121(7):1364-1378.e2
pubmed: 32532673
Nutrients. 2022 Mar 13;14(6):
pubmed: 35334873
Lancet. 2021 Jun 5;397(10290):2195-2211
pubmed: 34090606
Curr Opin Pulm Med. 2019 Nov;25(6):674-679
pubmed: 31567328
Am J Respir Crit Care Med. 2020 Jan 15;201(2):188-197
pubmed: 31601120
Antioxidants (Basel). 2021 Mar 19;10(3):
pubmed: 33808590
J Cyst Fibros. 2018 Mar;17(2):153-178
pubmed: 29506920
Nutrients. 2021 Dec 09;13(12):
pubmed: 34959965
Nutrients. 2021 Dec 10;13(12):
pubmed: 34959966
Pediatr Pulmonol. 2022 Apr;57(4):935-944
pubmed: 35018747
J Pathol. 2016 Jan;238(2):311-20
pubmed: 26365583
J Clin Endocrinol Metab. 2012 Apr;97(4):1082-93
pubmed: 22399505
Br J Nutr. 2019 Jan;121(2):195-201
pubmed: 30442206
Am J Respir Crit Care Med. 2018 Jan 15;197(2):214-224
pubmed: 28930490
N Engl J Med. 2010 Nov 18;363(21):1991-2003
pubmed: 21083385
Nutrition. 2019 Nov - Dec;67-68:110518
pubmed: 31473521
Nat Rev Gastroenterol Hepatol. 2016 Mar;13(3):175-85
pubmed: 26790364
Dig Dis Sci. 2016 Jan;61(1):198-207
pubmed: 26250833
J Pediatr. 2017 Feb;181S:S4-S15.e1
pubmed: 28129811
N Engl J Med. 2019 Nov 7;381(19):1809-1819
pubmed: 31697873
Clin Nutr. 1998 Oct;17(5):211-5
pubmed: 10205341
Front Endocrinol (Lausanne). 2022 Jul 12;13:935354
pubmed: 35903281